BioNTech - Wikipedia BioNTech SE ( biːˈɒntɛk bee-ON-tek; or baɪˈɒntɛk bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases
BioNTechs CTLA-4 drug improves survival in phase 3 cancer trial A closer look at phase 3 data on BioNTech and OncoC4’s anti-CTLA-4 antibody has shown the efficacy that excited analysts last week is offset by a challenging tolerability profile Analysts got
BioNTech and Bristol Myers Squibb Present First Global BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Bristol Myers Squibb, Duality Biologics, Fosun Pharma, Genentech
BioNTech | About BioNTech is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases We are committed to transforming how cancer is treated
BioNTech Consolidates mRNA Leadership with CureVac Acquisition . . . BioNTech SE announced late Wednesday that it has successfully secured the necessary threshold of CureVac NV shares to proceed with its takeover While this strategic move solidifies the company’s domestic dominance, investors remain focused on a challenging stock performance and emerging regulatory headwinds from the United States